Skip to main content
  • IGHID-World-Logo-Design-Research-New-Academic-Year

    IGHID Investigators Discuss Projects As New Academic Year Begins

    Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases (IGHID) contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations. Their multi-disciplinary findings will be u … Continued

  • kovarova-TB-Study.jpg

    Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis

    Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin. Read more.

  • Myron Cohen, MD-ID-faculty-in-covid-news-dec-24-30

    Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study

    Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). Read more.

  • lisa-hightow-weidman-md-mph

    Addressing Racism’s Role in the US HIV Epidemic: Qualitative Findings from Three “Ending the HIV Epidemic” Prevention Projects

    Researchers from the Institute for Global Health and Infectious Diseases, the Gillings School of Global Public Health, and Center for Health Equity Research reviewed qualitative data from three “Ending the HIV Epidemic” (EHE) projects, published in the July issue of Journal of Acquired Immune Deficiency Syndrome (JAIDS). In the article, Kate Muessig, PhD, associate professor in t … Continued

  • Uganda-malaria-Shelus-with-two-vendors-holding-training-certifications-Ross-Boyce-mentee

    Victoria Shelus Studies Antimalarial Drug Use and Practice at Drug Shops in Uganda

    Victoria Shelus studies antimalarial drug use and practice at drug shops in Uganda, building on the work of Dr. Ross Boyce. In the remote villages of Bugoye sub-county at the foot of Uganda’s Rwenzori Mountains a rolling landscape stretches across lush river valleys and steep hillsides. It’s the kind of terrain that might make for a beautiful and strenuous weekend hike for visito … Continued

  • Jon Juliano Headshot-$3.4-million-grant

    Juliano Receives $3.4 million to Study the Increase of Relapsing Malaria Species in Africa

    Jonathan Juliano, MD, MPSH, Professor of Infectious Diseases and Associate Director of the Institute for Global Health and Infectious Diseases, with fellow IDEEL investigators Jessica Lin, MD, MSCR, and Jonathan Parr, MD, MPH, and co-PIs from the University of Florida (UF) and Centre Pasteur Cameroon, has received a $3.4 million R01 grant award to study the changing epidemiology … Continued

  • waltmann-meshnick-scaled-e1656101391554-1024x793

    Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens

    Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination treatment sulfadoxine-pyrimethamine (SP), given for intermittent preventive therapy of malaria in pregnancy (IPTp), is one of the few existing interventions that improve outcomes for both mother and baby, despite widespread SP-resistant malaria. Compell … Continued

  • ross-boyce-cdc-renews-funding

    CDC renews five-year funding for vector-borne disease threats

    The Center for Disease Control and Prevention (CDC) has announced the five-year funding renewal of the Southeastern Center for Vector-Borne Diseases (SECVBD), an interdisciplinary team of researchers that includes UNC’s Ross Boyce, MD, MSc, a member of the UNC Institute for Global Health & Infectious Diseases and assistant professor in infectious diseases and epidemiology, an … Continued

  • Rutstein Appointed to HIGH IRI Training Program

    Sarah Rutstein, MD, PhD, a physician scientist and senior clinical fellow in the Division of Infectious Diseases in the Department of Medicine, has been accepted to the HIV Infectious Disease and Global Health Implementation Research Institute (HIGH IRI) through the Center for Dissemination and Implementation at the Institute for Public Health at Washington University in St. Loui … Continued

  • Welcome to our 2022-2023 ID fellows!

    We are excited to announce that we have matched 4 physicians to the ID Fellowship for the 2022-2023 academic year! Drs. Briana Castillo, Alex Commanday, John Franzone, and Stephanie Sweitzer will be joining UNC in July. Interests: HIV, HCV, LGBTQIA+ health, and substance use Residency: University of Illinois Chicago Interests: Domestic HIV implementation research Residency: Emory … Continued